INTERNATIONAL PATENT: 4E THERAPEUTICS, INC. FILES APPLICATION FOR "DEUTERATED MNK INHIBITORS"

GENEVA, Jan. 6 -- 4E THERAPEUTICS, INC. (3800 N. Lamar Blvd.Suite 200Austin, Texas 78756) filed a patent application (PCT/US2025/035247) for "DEUTERATED MNK INHIBITORS" on Jun 25, 2025. With publication no. WO/2026/006442, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SAHN, James J. (c/o 4E Therapeutics, Inc.3800 N. Lamar Blvd.Suite 200Austin, Texas 78756)

Abstract: The present disclosure provides deuterated MNK inhibitor compounds, as well as compositions and methods of use thereof.

For more information:https://paten...